1. SA Berson, RS Yalow. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 38:1996, 1959.

2. BD Albertson, FP Haseltine. Non-radiometric Assays, Technology and Application in Polypeptide and Steriod Hormone Detection. New York: Alan R. Liss, 1988.

3. DS Skelley, LP Brown, PK Besch. Radioimmunoassay. Clin Chem 19:146, 1973.

4. GC Oliver, BM Parker, DL Brasfield, CW Parker. The measurement of digitoxin in human serum by radioimmunoassay. J Clin Invest 47:1035, 1968.

5. J Landon, AC Moffat. The radioimmunoassay of drugs. Analyst 101:225, 1976.

Copyright 2002 by Marcel Dekker. All Rights Reserved.

I Jonsdottir, HP Ekre, P Perlmann. Comparative study of pituitary and bacteria-derived human growth hormone by monoclonal antibodies. Mol Immunol 20:871, 1983.

R Ekins. In: R Ekins, A Vollers, A Bartlett, D Bidwell, eds. Merits and disadvantages of different labels and methods of immunoassay. Immunoassays for the 80s. Baltimore, MD: University Park Press, 1981, p 5.

R Ekins. In: A Albertini, R Ekins, eds. Toward Immunoassays of Greater Sensitivity, Specificity and Speed: An Overview. Monoclonal Antibodies and Developments in Immunoassays. Amsterdam: Elsevier, 1981, p 3.

L Wide, H Bennich, SGO Johansson. Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 2:1105, 1967.

LEM Miles, CN Hales. Labelled antibodies and immunological assay systems. Nature 219:186, 1968.

GM Addison, CN Hales. Two site assay of human growth hormone. Horm Metab Res 3:59, 1971.

VP Shah, et al. Analytical methods validation—Bioavailability, bioequivalence, and pharmacokinetic studies. J Pharm Sci 81:309, 1992.

D Rodbard, JE Lewald. In: E Diczfalusy, A Diczfalusy, eds. Computer analysis of radioligand assay and radioimmunoassay data. Steroid Assay by Protein Binding. Karolinska Symposia on Research Methods in Reproductive Endocrinology, WHO/ Karolinska Institut, Stockholm, 1970, p 79.

D Rodbard, PJ Munson, A De Lean. Improved curve-fitting, parallelism testing, characterisation of sensitivity and specificity, validation, and optimization for ra-dioligand assays. In: Radioimmunoassay and Related Procedures in Medicine 1, Vienna: International Atomic Energy Agency, 1978, p 469. PJ Goadsby, et al. An interactive, readily transportable program using a log-logit transformation for the analysis of radioimmunoassay data. Comput Meth Programs Biomed 23:263, 1986.

PJ Geiger. Radioimmunoassay data handling and calculations with a graphics statistics comptuer program. Biochem Med Metab Biol 48:74, 1992. TM Jackson, RP Ekins. Theoretical limitations on immunoassay sensitivity. J Immunol Meth 87:13, 1986.

RP Ekins, S Dakubu. The development of highly sensitive pulsed light, time-resolved fluoroimmunoassays. Pure Appl Chem 57:473, 1985. I Weeks, M Sturgess, K Siddle, et al. A high sensitivity immunochemiluminometric assay for human thyrotrophin. Clin Endocrinol 20:489, 1984. LJ Kricka. Chemiluminescent and bioluminescent techniques. Clin Chem 37:1472, 1991.

GC Schussler. Diazepam competes for thyroxine binding sites. J Pharmacol Exp Ther 178:204, 1971.

SG Hillier, BG Brownsey, EH Cameron. Some observations on the determination of testosterone in human plasma by radioimmunoassay using antisera raised against testosterone-3-BSA and testosterone-11a-BSA. Steroids 21:735, 1973. S Bauminger, HR Lindner, A Weinstein. Properties of antisera to progesterone and to 17-hydroxyprogesterone elicited by immunization with the steroids attached to protein through position 7. Steroids 21:947, 1973.

T Nambara, M Numazawa, Y Tsuchida, T Tanaka, Specificity of antiserum raised Marcel Dekker. All Rights Reserved.

against estradiol using 6-O-carboxymethyloxime-bovine serum albumin conjugate. Chem Pharm Bull 24:1510, 1976.

O Chappey, P Sandouk, JM Scherrmann. Modulation of the specificity of anti-hapten antibodies. J Clin Immunoassay 15:51, 1992.

AL Neese, LF Soyka. Mis au point d'une methode dosage radioimmunologique pour la theophylline; Application chez l'enfant premature. Clin Pharmacol Ther 5: 633, 1977.

VP Butler, JP Chen. Digoxin specific antibodies. Proc Natl Acad Sci (USA) 57: 71, 1977.

AJ Lomant, G Fairbanks. Chemical probes of extended biological structures: Synthesis and properties of the cleavable protein crosslinking reagent [35S] dithiobis (succinimidyl propionate). J Mol Biol 104:243, 1976.

S Yoshitake, Y Yomada, E Ishikawa, R Masseyeff. Conjugation of glucose oxidase from aspergillus niger and rabbit antibodies using N-hydroxysuccinimide ester of N-(4-carboxycyclohexylmethyl)-maleimide. Eur J Biochem 101:395, 1979. FRN Gurd. Carboxymethylation. Meth Enzymol 11:532, 1967. AM Crestfield, S Moore, WH Stein. The preparation and enzymatic hydrolysis of reduced and S-carboxymethylated proteins. J Biol Chem 238:622, 1963. Z Grabarek, J Gergely. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 185:131, 1990.

MA Gilles, AQ Hudson, CL Borders Jr. Stability of water-soluble carbodiimides in aqueous solution. Anal Biochem 184:244, 1990.

JV Staros, RW Wright, DM Swingle. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem 156: 220, 1986.

DG Smyth, OO Blumenfeld, W Konigsberg. Reaction of N-ethylmaleimide with peptides and amino acids. Biochem J 91:589, 1964.

M De Villiers, D Parkin, P Van Jaarsveld, B Vander Walt. A radioimmunoassay for metoclopramide. J Immunol Meth 103:33, 1987.

S Spector, B Berkowitz, EJ Flynn, B Peskar. Antibodies to morphine, barbiturates, and serotonin. Pharmacol Rev 25:281, 1973.

JPP Tyler, JF Hennam, JR Newton, WP Collins. Radioimmunoassay of plasma testosterone without chromatography: A comparison of four antisera, and the evaluation of a novel approach to liquid scintillation counting. Steroids 22:871, 1973.

A Muckerheide, RJ Apple, AJ Pesce, JG Michael. Cationization of protein antigens. J Immunol 138:833, 1987.

S Schwarz, P Berger, G Wick. Epitope-selective, monoclonal-antibody-based im-munoradiometric assays of predictable specificity for different measurement of choriogonadotropin and its subunits. Clin Chem 31:1322, 1985. BF Erlanger, R Borek, SM Beiser, S Lieberman. Steroid protein conjugate, I. Preparation and characterization of conjugates of bovine serum albumin with testosterone and with cortisone. J Biol Chem 228:713, 1957.

BF Erlanger, R Borek, SM Beiser, S Lieberman. Steroid protein conjugates, II. Preparation and characterization of conjugates of bovine serum albumin with progesterone, deoxycorticosterone, and estrone. J Biol Chem 234:1090, 1959.

BF Erlanger. Principles and methods for the preparation of drug protein conjugates for immunological studies. Pharmacol Rev 25:271, 1973.

GE Abraham, PK Grover. Covalent linkage of hormonal haptens to protein carriers for use in radioimmunoassay. In: WD Odell, WH Daughaday, eds. Principle of Competitive Protein-Binding Assays. Philadelphia: Lippincott, 1974, p 134. UF Axen. N,N'-carbonyldiimidzole as coupling reagent for the preparation of bovine serum albumin conjugates. Prostaglandins 5:45, 1974.

JR Vaughan Jr, RL Osato. Preparation of peptides using mixed carbonic-carboxylic acid anhydrides. J Am Chem Soc 74:676, 1952.

JF Vaughan Jr. Acylalkylcarbonates as acylating agents for the synthesis of pep-tides. J Am Chem Soc 73:3547, 1951.

NS Ranadive, AH Sehon. Antibodies to serotonin. Can J Biochem. 45:1701, 1967. S Aurameas, T Termynck. The cross-linking of proteins with gluteraldehyde and its use for the preparation of immunoabsorbents. Immunochemistry 6:53, 1969. DH Catlin, JC Schaeffer, MB Liewen. 2-Diazomorphine directed antiserum: Determination of morphine in brain after naloxone challenge in morphine pellet implanted mice. Life Sci 20:123, 1977.

B Rubin. Studies on the induction of antibody synthesis against sulfanilic acid in rabbits, I. Effect of the number of hapten molecules introduced in homogeneous protein on antibody synthesis against the hapten and the new antigenic determinants. Eur J Immunol 2:5, 1972.

K Wicher, M Schwartz, CE Arbesman, F Milgrom. Immunologic studies of aspirin, I. Antibodies to aspiryl-protein conjugates. J Immunol 101:342, 1968. N Hanna, E Jarosch, S Leskowitz. Altered immunogenicity produced by change in mode of linkage of hapten to carrier. Proc Soc Exp Biol Med 140:89, 1972. K Hoffman, P Samarazeewa, EK Smith, AE Kellie. Radioimmunoassay of steroids, the role of the ''bridge'' linking the steroid hapten to the protein carrier. J Steroid Biochem 6:91, 1975.

CS Walker, SJ Clark, HH Wotiz. Factors involved in the production of specific antibodies to estriol and estradiol. Steroids 21:259, 1973.

GD Niswender. Influence of the site of conjugation on the specificity of antibodies to progesterone. Steroids 22:413, 1973.

M Koida, M Takahashi, S Muraoka, H Kaneto. Antibodies to BSA conjugates of morphine derivatives: Strict dependency of the immunological specificity on the hapten structure. Jpn J Pharmacol 24:165, 1974.

S Spector. Radioimmunoassay of drugs. In Radioimmunoassay and Related Procedures in Medicine, Vol. II. International Atomic Energy Association, 1974, p 233. S Rothchild. Tritium labeling by other methods. In S Rothchild, ed. Advances in Tracer Methodology, Vol. 1. New York: Plenum Press, 1963, p 50. JG Spenney, BJ Johnson, BI Hirschowitz, AA Mihas, R Gibson. An 125I radioimmu-noassay for primary conjugated bile salts. Gastroenterology 72:305, 1977. C Gomez-Sanchez, L Milewich, OB Holland. Radioiodinated derivatives for steroid radioimmunossay. Application to the radioimmunoassay of cortisol. J Lab Clin Med 89:902, 1977.

AE Bolton, WM Hunter. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J 133:529, 1973.

WJ Rzeszotarski, C Paik, WC Eckelman, RC Reba. The synthesis of chelating agents for the preparation of drug derivatives. J Labeled Comp Radiopharm 13: 171, 1977.

JR Little, TJ Blanke, KD Little. A new method of radioactive labelling of polyanio-nic macromolecules for radioimmunoassay. Eur J Immunol 5:373, 1975. FC Greenwood, WM Hunter, GS Glover. The preparation of 131I labeled human growth hormone of high specific radioactivity. Biochem J 89:114, 1963. E Samols, HS Wilteams. Trace-labelling of insulin with iodine. Nature 190:1211, 1961.

WR Butt. The iodination of follicle-stimulating and other hormones for radioimmunoassay. J Endocrinol 55:453, 1972.

JI Thorell, BG Johansson. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta 251:363, 1971.

EHD Cameron, JJ Scarisbrick, SE Morris, SG Hillier, G Read. Some aspects of the use of 125I-labeled ligands for steroid radioimmunoassay. J Steroid Biochem 5: 749, 1974.

WM Hunter. Preparation and assessment of radioactive tracers. Br Med Bull 30: 18, 1974.

JP Gosling. A decade of development in immunoassay methodology. Clin Chem 36:1408, 1990.

TM Jackson, NJ Marshall, RP Ekins. Optimization of immunoradiometric assays. In: WM Hunter, JET Corrie, eds. Immunoassays for Clinical Chemistry. Edinburgh: Churchill Livingstone, 1983, p 557.

T Porstmann, ST Kiessig. Enzyme immunoassay techniques, an overview. J Immunol Meth 150:5, 1992.

K Helgert, et al. Enzyme immunoassay—Principle and application. Pharmazie 44: 745, 1989.

E Ishikawa. Development and clinical application of sensitive enzyme immunoas-say for macromelecular antigens. A review. Clin Biochem 20:375, 1987. E Soini, J Hemmila. Fluoroimmunoassay: Present status and key problems. Clin Chem 25:353, 1979.

I Wieder. Background rejection in fluorescence immunoassay. In: Proc 6th Int Conf Immunofluorescence and Related Staining Techniques. Vienna: Elsevier, 1978, p 67.

WB Dandliker, GA Feigen. Quantification of the antigen-antibody reaction by the polarization of fluorescence. Biochem Biophys Res Commun 5:299, 1961. IM Roberts, et al. A comparison of the sensitivity and specificity of enzyme immunoassays and time-resolved fluoroimmunoassay. J Immunol Meth 143:49, 1991. I Hemmila, S Dakubu, VM Mukkala, H Siitari, T Lovgren. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 137:335, 1984. T Lovegren, I Hemmila, K Pettersson, P Halonen. Time-resolved fluorometry in immunoassay. In: WP Collins, ed. Alternative Immunoassays. Chichester, UK: Wiley, 1985, p 203.

N Filipescu, WF Sager, FA Serafin. Substituent effects on intramolecular energy transfer. II. Fluorescence spectra of europium and terbium beta-diketone chelates. J Phys Chem 68:3324, 1964.

M DeLuca, W McElroy. Bioluminescence and Chemiluminescence. New York: Academic Press, 1981.

LJ Kricka. Selected strategies for improving sensitivity and reliability of immunoassays. Clin Chem 40:347, 1994.

F Kohen, M Pazzagli, M Serio, J deBoever, D Vanderkerckhove. Chemiluminescence and bioluminescence immunoassay. In: WP Collins, ed. Alternative Immunoassays. New York: Wiley, 1985, p 103.

GHG Thorpe, LJ Kricka. Enhanced chemiluminescent reactions catalysed by horseradish peroxidase. Meth Enzymol 133:331, 1986.

AP Schaap, H Akhavan, LJ Romano. Chemiluminescent substrates for alkaline phosphatase application to ultrasensitive enzyme-linked immunoassays and DNA probes. Clin Chem 35:1863, 1989.

LJ Kricka. Ligand Binder Assays. New York: Marcel Dekker, 1985, p 199. TJN Carter, CJ Groucutt, RAW Stott, GHG Thorpe. Enhanced luminescent and luminometric assay. European Patent 0087959, 1985.

LJ Kricka, M O'Toole, GHG Thorpe, TP Whitehead. Enhanced luminescent for luminometric assay. US Patent 4729950, 1988.

E Ishikawa, K Kato. Ultrasensitive enzyme immunoassay. Scand J Immunol 8:43, 1978.

J Wannlund, M Deluce. A sensitive bioluminescent immunoassay for dinitrophenol and trinitro toluene. Anal Biochem 22:385, 1982.

CJ Stanley, RB Cox, MF Cardosi, et al. Amperometric enzyme amplified immunoassay. J Immunol Meth 112:153, 1988.

PMS Clark, CP Price. Enzyme amplified immunoassays: A new sensitive assay of thyrotropin evaluated. Clin Chem 32:88, 1986.

S Avrameas. Amplification systems in immunoenzymatic techniques. J Immunol Meth 150:23, 1992.

G Gitlin, EA Bayer, M Wilchek. Studies of the biotin-binding site of avidin. Bio-chem J 242:923, 1987.

I Chaiet, FJ Wolf. The properties of streptavidin, a biotin-binding protein produced by Streptomycetes. Arch Biochem Biophys 106:1, 1964.

RC Duhamel, JS Whitehead. Prevention of nonspecific binding of avidin. Meth Enzymol 184:201, 1990.

A Johannsson, DH Ellis, DL Bates. Enzyme amplification for IAs detection limit of 1/100 of an attomole. J Immunol Meth 87:7, 1986.

CH Self. Enzyme amplification—A general method applied to provide an immu-noassisted assay for placental alkaline phosphatase. J Immunol Meth 76:389, 1985. H Arakawa, M Maeda, A Tsuji. Chemiluminescence enzyme immunoassay for thyroxin with the use of glucose oxidase and a bis(2,4,6-trichlorophenyl) oxalate-fluo-rescent dye system. Clin Chem 31:430, 1985.

L Chedid, E Lederer. Past, present and future of the synthetic immunoadjuvant MDP and its analogs. Biochem Pharmacol 27:2183, 1978.

GW Boyd, WS Peart. The production of high-titre antibody against free angiotensin II. Lancet 2 560:129, 1968.

J Vaitukaitis, JB Robbins, E Nieschlag, GT Ross. A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol 33:988, 1971.

HN Eisen. Equilibrium dialysis for measurement of antibody-hapten affinities. In: HN Eisen, ed. Methods in Medical Research, Vol 10. Chicago: Yearbook Medical Publishing, 1964, p 106.

PM Keane, WHC Walker, J Gauldie, GE Abraham. Thermodynamic aspects of some radioassays. Clin Chem 22:70, 1976.

DL DiPietro, RD Brown, CA Strott. A pregnenolone radioimmunoassay utilizing a new fractionation technique for sheep antiserum. J Clin Endocrinol Metab 35: 729, 1972.

JB Robbins, J Haimovich, M Sela. Purification of antibodies with immunoadsor-bents prepared using bromoacetyl cellulose. Immunochemistry 4:11, 1967. RJ Hill. Elution of antidbodies from immunoadsorbents: Effect of dioxane in promoting release of antibody. J Immunol Meth 1:231, 1972.

LG Hoffmann, C-Y Kuo. Immunoadsorbents for the isolation of high-affinity anti-hapten antibodies in high yield. J Immunol Meth 15:101, 1977. TM Murray, HT Keutmann. The immunochemical specificity of antisera to bovine parathyroid hormone: An approach to region-specific radioimmunoassay. J Endo-crinol 56:493, 1973.

G Galfre, C Milstein. Preparation of monoclonal antibodies: Strategies and procedures. In: S Colowick, N Kaplan, eds. Methods in Enzymology 73. New York: Academic Press, 1981, p 1.

JW Littlefield. Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science 145:709, 1964.

CA Caulcott, R Boraston, C Hill, et al. Production and purification of monoclonal antibodies. In: WP Collins, ed. Complementary Immunoassays. Chichester, UK: Wiley, 1988, p 27.

G Kohler, C Milstein. Continuous culture of fused cells secreting specific antibody of predefined specificity. Nature 256:495, 1975.

RR Hardy. Purification and characterization of monoclonal antibodies. In: DM Weir, LA Herzenberg, C Blackwell, LA Herzenberg, eds. Handbook of Experimental Immunology, Immunochemistry, 1. Oxford: Blackwell Scientific, 1986, p 13.1. JR Deschamps, EK Hidreth, D Derr, JT August. A high-performance liquid chro-matography procedure for the purification of mouse monoclonal antibodies. Anal Biochem 147:451, 1985.

LM Boscato, GM Egan, MC Stuart. Specificity of two-site immunoassays. J Immunol Meth 117:221, 1989.

LM Boscato, MC Stuart. Incidence and specificity of interference in two-site immunoassays. Clin Chem 32:1491, 1986.

JC Cresto, RS Yalow. Anomalously ascending standard curves in the radioimmuno-assay of insulin, human growth hormone and ACTH. Horm Metab Res 5:1, 1974.

TH Weber, KI Kapyaho, P Tanner. Endogenous interference in immunoassays in clinical chemistry. A review. Scand J Clin Lab Invest 50(suppl 201): 77, 1990. DW Rea, ME Ultee. A novel method for controlling the pepsin digestion of antibodies. J Immunol Meth 157:165, 1993.

SJ Boguslawski, et al. Improved procedure for preparation of F (ab')2 fragments of mouse IgGs by papain digestion. J Immunol Meth 120:51, 1989.

A Coulter, R Harris. Simplified preparation of rabbit fab fragments. J Immunol Meth 59:199, 1983.

JW Goding. Use of staphylococcal protein A as an immunological reagent. J Immunol Meth 20:241, 1978.

J Rousseaux, et al. Optimal conditions for the preparation of Fab and F (ab') fragments from monoclonal IgG of different rat IgG subclasses. J Immunol Meth 64: 141, 1983.

JL Guesdon, F Naquira Velarde, S Avrameas. Solid phase immunoassays using chimera antibodies prepared with monoclonal or polyclonal anti-enzyme and anti-erythrocyte antibodies. Ann Immunol 1396:265, 1983.

B Porstmann, S Avrameas, T Ternynck, T Porstmann, B Micheel, JL Guesdon. An antibody chimera technique applied to enzyme immunoassay for human alpha-1-feto-protein with monoclonal and polyclonal antibodies. J Immunol Meth 66:179, 1984. C Milstein, AC Cuello. Hybrid hybridoma production of bi-specific monoclonal antibodies. Immunol Today 5:299, 1984.

G Spira, A Bargellesi, JL Teillaud, MD Scharff. The identification of monoclonal class switch variants by Sib selection and an ELISA assay. J Immunol Meth 74: 307, 1984.

MR Suresh, AC Cuello, C Milstein. Bi-specific monoclonal antibodies from hybridomas. Meth Enzymol 121:210, 1986.

LK Sun, P Curtis, E Rekowicz-Szulcyznska, et al. Chimeric antibody with human constant regions and mouse variable region directed against carcinoma-associated antigen 17-1A. Proc Natl Acad Sci (USA) 84:214, 1987.

L Riechmann, M Clark, H Waldmann, G Winter. Reshaping human antibodies for therapy. Nature 332:323, 1988.

RS Yalow, SA Berson. Special problems in the radioimmunoassay of small polypeptides. In: M Margoulies, ed. Protein and Poly-peptide Hormones. Excerpta Medica Foundation, Amsterdam, 1969, p 71.

G Scatchard. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660, 1949.

MW Steward. Introduction to methods used to study antibody-antigen reactions. In: DM Weir, ed. Handbook of Immunological Methods. 3rd ed. Oxford: Blackwell Scientific, 1981, p 16.1.

CN Hales, PJ Pandle. Immunoassay of insulin-antibody precipitate. Biochem J 88: 137, 1963.

CA Velasco, HS Cole, RA Camerini-Davalos. Radioimmunoassay of insulin, with use of an immunosorbent. Clin Chem 20:700, 1974.

K Catt, GW Tregear. Solid-phase radioimmunoassay in antibody-coated tubes. Science 158:1570, 1967.

BA Baldo, ER Tovey. Protein Blotting: Methodology, Research and Diagnostic Applications. Basel: S Karger, 1989.

LA Blankstein, L Dohrman. An advanced affinity membrane for immunodiagnostic tests, Am Clin Products Rev 33, 1985.

AJ Pesce, DJ Ford, M Gaizutis, VW Pollak. Binding of protein to polystyrene in solid-phase immunoassay. Biochem Biophys Acta 492:399, 1977. LA Cantarero, JE Butler, JW Osborne. The adsorptive characteristics of proteins for polystyrene and their significance in solid-phase immunoassays. Anal Biochem 105:375, 1980.

JL Brash, DJ Lyman. Adsorption of plasma proteins in solution to uncharge surfaces. J Biomed Mater Res 3:175, 1969.

JH Peterman, PJ Tarcha, VP Chu, JE Butler. The immunochemistry of sandwich ELISAs. IV. A comparison of the antigen capture capacity of antibodies adsorbed or covalently attached to polystyrene. J Immunol Meth 111:271, 1988. E Engvall, K Jonsson, P Perlmann. Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme labelled antigen and antibody coated tubes. Biochem Biophys Acta 251:427, 1971. EE Howell, J Nasser, KJ Schray. Coated tube immunoassay: Factors affecting sensitivity and effects of reversible protein binding to polystyrene. J Immunoassay 2: 205, 1981.

HB Bull. Adsorption of bovine serum albumin on glass. Biochem Biophys Acta 19:464, 1956.

E Ishikawa, Y Hamaguchi, M Imagawa, et al. An improved preparation of antibody-coated polystyrene beads for sandwich enzyme immunoassays. J Immunoassay 1: 385, 1980.

M Kemeny, SJ Challacombe. Microtiter plates and other solid-phase supports, In: DM Kemeny, SJ Challacombe, eds. ELISA and Other Solid-Phase Immunoassay. London: Wiley, 1987, p 31.

RP Pratt, P Roser. Comparisons of blocking reagents for ELISA. Nunc Bulletin 181:1, 1984.

PJ Tarcha. The chemical properties of solid-phases and their interaction with proteins. In: LE Butler, ed. Immunochemistry of Solid-Phase Immunoassay. Boca Raton, FL: CRC Press, 1991, p 27.

SJ Kennel. Binding of monoclonal antibody to protein in fluid phase and bound to solid supports. J Immunol Meth 55:1, 1982.

ME Soderquist, AG Walton. Structural changes in proteins absorbed on polymer surfaces. J Colloid Interface Sci 75:386, 1980.

SE Dierks, JE Butler, HB Richerson. Altered recognition of surface antigen-bound antibodies in the ELISA. Mol Immunol 23:403, 1986.

EW Voss Jr, RW Watt. Steric orientation of hapten groups and the effects. Immunochemistry 14:741, 1977.

KS Joshi, JE Butler. The immunochemistry of sandwich ELISAs. V. The capture antibody performance of polyclonal antibody-enriched fractions prepared by various methods. Mol Immunol 29:971, 1992.

C Creminon, O Dery, Y Frobert, J-Y Couraud, P Pradelles, J Grassi. Two-site immunometric assay for substance P with increased sensitivity and specificity. Anal Chem 67:1617, 1995.

LX Tiefenauer, RY Andres. Biotinyl-estradiol derivatives in enzyme immunoassays: Structural requirements for optimal antibody binding. J Steroid Biochem 35: 633, 1990.

WM Hunter. Optimization of RIA: Some simple guidelines, In: WM Hunter JET Corrie, eds. Immunoassays for Clinical Chemistry. London: Churchill Livingstone, 1983, p 69.

HR Lindner, E Perel, A Friedlander, A Zeitlen. Specificity of antibodies to ovarian hormones in relation to the site of attachment of the steroid hapten to the peptide carrier. Steroids 19:357, 1972.

A Zettner, PE Duly. Principles of competitive binding assays (saturation analysis) II. Sequential saturation. Clin Chem 20:5, 1974.

R Malvano, E Rolleri, U Rosa. Standardization and control of steroid radioimmunoassays. In: Radioimmunoassay and Related Procedures in Medicine, Vol II. Vienna: International Atomic Energy Agency, 1974, p 112.

JJ Pratt, MG Woldring. Radioimmunoassay specificity and the ''first-come, first-served effect.'' Clin Chim Acta 68:87, 1976.

A Jacklitsch. Separation-free enzyme immunoassay for haptens. In: TT Ngo and HM Lenhoff, eds. Enzyme-mediated Immunoassay. New York: Plenum Press, 1985, p 33.

WB Dandliker, RJ Kelly, J Dandliker, J Farquhar, J Levin. Flourescence polarization immunoassay theory and experimental method. Immunochemistry 10:219, 1973.

EF Ullman, PL Khanna. Fluorescence excitation transfer immunoassay. Meth En-zymol 74:28, 1981.

DJ Litman, TM Hanlon, EF Ullman. Enzyme channeling immunoassay. A new homogeneous enzyme immunoassay technique. Anal Biochem 106:223, 1980. I Gibbons, R Armenta, RK DiNello, et al. Nonseparation enzyme channeling immu-nometric assays. Meth Enzymol 136:93, 1987.

RF Zuk, VK Ginsberg, T Houts, et al. Enzyme immunochromatography—A quantitative immunoassay requiring no instrumentation. Clin Chem 31:1144, 1985. DR Henderson, SB Friedman, JB Harris, et al. ''CEDIA,'' a new homogeneous immunoassay system. Clin Chem 32:1637, 1986.

PL Khanna, TE Worthy. A recombinant protein-based homogeneous immunoassay. Am Clin Lab, Oct 14, 1989.

PL Khanna, RT Dworschack, WB Manning, et al. A new homogeneous enzyme immunoassay using recombinant enzyme fragments. Clin Chim Acta 185:231, 1989.

M Evans, DA Palmer, JN Miller, MT French. Flow injection fluorescence immunoassay for serum phenytoin using perfusion chromatography. Anal Proc 31:7, 1994. KT Kivisto, et al. Therapeutic cyclosporine monitoring. Comparison of radioimmunoassay and high performance liquid chromatography methods in organ transplant recipients. Ther Drug Monit 12:353, 1990.

A Lindholm, et al. Comparative analyses of cyclosporine in whole blood and plasma by radioimmunoassay, fluorescence polarization immunoassay, and high performance of liquid chromatography. Ther Drug Monit 12:344, 1990. DW Holt, et al. HPLC and Cyclo-Trac SP radioimmunoassay compared for monitoring cyclosporine. Clin Chem 38:442, 1992.

RG Buice et al. Analytical methodologies for cyclosporine pharmacokinetics—A comparison of radioimmunoassay with high performance liquid chromatography. J Liq Chromatogr 10:421, 1987.

G Schumann, D Petersen, PF Hoyer, K Wonigeit. Monitoring cyclosporine A (Ciclosporin, INN) concentrations in whole blood: Evaluation of the EMIT™ assay in comparison with HPLC and RIA. Eur J Clin Chem Clin Biochem 31:381, 1993.

180. A Broughton, JE Strong, GP Bodey. Radioimmunoassay of sisomicin. Antimicrob Agents Chemother 9:247, 1976.

181. WA Colburn, AR DiSanto, SS Stubbs, RE Monovich, KA DeSante. Pharmacokinetic interpretation of plasma cortisol and cortisone concentrations following a single oral administration of cortisone acetate to human subjects. J Clin Pharmacol 20:428, 1980.

182. DEH Llewelyn, SG Hillier, GF Read. The use of multivariable standard curves in the radioimmunoassay of testosterone and 5a-dihydrotestosterone. Steroids 28:339, 1976.

183. JW Lee, JD Hulse, WA Colburn. Surrogate biochemical markers: Precise measurement for strategic drug and biologics development. J Clin Pharmacol 35:464, 1995.

184. P Carter. Preparation of ligand-free human serum for radioimmunoassay by adsorption on activated charcoal. Clin Chem 24:362, 1978.

185. L Peng, GJ Calton, J Burnett. Stability of antibody attachment in immunosorbent chromatography. Enzyme Microb Technol 8:681, 1986.

186. RH Ng. Product Information, Laboratorian Desk Reference. 2nd ed. Wayne, MI: Clinical Ligand Assay Society, 1993.

187. NP Kubasik, NS Norkus, HE Sim. Comparison of commercial kits for radioimmunoassay: II. The radioimmunoassay of serum digoxin using iodinated tracer. Clin Biochem 7:307, 1974.

188. AA MacKinney Jr, GH Burnett, RL Conklin, GW Wasson. Comparison of five radioimmunoassays and enzyme bioassay for measurement of digoxin in blood. Clin Chem 21:857, 1975.

189. H Muller, EH Graul, H Brauer. Different results produced by five radioimmunoassays for determination of digitalis in serum. Eur J Clin Pharmacol 10:227, 1976.

190. JW Lee, JE Pedersen, TL Moravetz, et al. Sensitive and specific radioimmunoas-says for opiates using commercially available materials. I: Methods for the determinations of morphine and hydromorphone. J Pharm Sci 80:284, 1991.

191. RV Weimer. MRS Catalog Primary Antibodies. 3rd ed. Brimingham, MI: MRS, 1995.

192. W Linscott's Directory. 7th ed. Santa Rosa, CA, 1993.

193. D Rodbard, W Bridson, PL Rayford. Rapid calculation of radioimmunoassay results. J Lab Clin Med 74:770, 1969.

194. D Rodbard, JE Lewald. Computer analysis of radioligand assay and radioimmunoassay data. Acta Endocrinol suppl 64(147):79, 1970.

195. D Rodbard, DM Hutt. Statistical analysis of radioimmunoassays and immunoradio-metric (labelled antibody) assays: A generalized weighted, iterative, least-squares method for logistic curve fitting. In: Radioimmunoassay and Related Procedures in Medicine, Vol I. Vienna: International Atomic Energy Agency, 1974, p 165.

196. WG Duddleson, AR Midgley Jr, GD Nswinder. Computer program sequence for analysis and summary of radioimmunoassay data. Comput Biomed Res 5:205, 1975.

197. KF Hatch, E Coles, H Busey, SC Goldman. End-point parameter adjustment on a small desk-top programmable calculator for logit-log analysis of radioimmunoassay data. Clin Chem 22:1383, 1976.

HE Grotjan Jr, E Steinberger. Radioimmunoassay and bioassay data processing using a logistic curve fitting routine adapted to a desk top computer. Comput Biol Med 7:159, 1977.

DS Riggs. The Mathematical Approach to Physiological Problems. Cambridge, MA: MIT Press, 1963, p 58.

D Rodbard, RH Lenox, HL Wray, D Ramseth. Statistical characterization of the random errors in the radioimmunoassay dose-response variable. Clin Chem 22:350,

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment